Health Care M&A Deals, Week Ending March 29, 2019

Health Care M&A Deals, Week Ending March 29, 2019

The Health Care M&A Deals Chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Guardant Health, Inc. Bellwether Bio, Inc. N/A AstraZeneca plc Collaboration on trastuzumab deruxtecan $1,350,000,000 eHealth Acquirer Target Price Netmeds Marketplace Pvt. Ltd. KiViHealth $10,000,000 Zyus Life Sciences Inc. Clinical health informatics platform $2,386,020... Read More »
Health Care M&A Deals, Week Ending March 29, 2019

Health Care M&A Deals, Week Ending March 8, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care     Acquirer Target Price AbleTo, Inc. Joyable N/A Biotechnology     Acquirer Target Price Biogen Inc. Nightstar Therapeutics plc $877,000,000 Pfizer Inc. License to an immune tolerance therapy N/A Oncternal Therapeutics, Inc GTx, Inc. N/A... Read More »
Health Care M&A Deals, Week Ending March 29, 2019

Health Care M&Deals, Week Ending February 22, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Merck & Co., Inc. Immune Design $300,000,000 Janssen Biotech, Inc. Collaboration on novel integrin therapeutics N/A ICON plc MolecularMD N/A eHealth Acquirer Target Price Harris Computer Systems Collain Healthcare, LLC N/A symplr API Healthcare N/A... Read More »